Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Chronic Pain Treatment Market Grown from 2024 to 2025?

Recent years have seen significant expansion in the chronic pain treatment market size. Predicted growth from $99.64 billion in 2024 to $109.05 billion in 2025, with a compound annual growth rate (CAGR) of 9.4%, indicates a strong market trend. Factors like an aging demographic, the increasing incidence of chronic conditions, heightened awareness about pain management, an increase in prescribed opioid usage, and broadening health insurance coverage contribute to this historical growth.

What Growth Rate Is Anticipated for the Chronic Pain Treatment Market in the Coming Years?

In the coming years, the market size for chronic pain treatment is set to witness significant growth, increasing to $155 billion in 2029 at a CAGR of 9.2%. This projected growth during the forecast period can be credited to the shift towards non-opioid alternatives, increase in government funding dedicated to pain research, the rising demand for tailored medicinal solutions, a growing trend in the utilization of digital tools for pain management, and enhanced usage of AI in diagnosing and planning pain treatment. The estimate period also highlights several emerging trends including improvements in the field of neuromodulation therapies, the incorporation of telemedicine in providing pain care, the development of treatments based on cannabinoids, emphasis on multidisciplinary treatment strategies, and the growth of wearable devices for monitoring pain.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24504&type=smp

Who Are the Leading Companies in the Chronic Pain Treatment Market?

Major companies operating in the chronic pain treatment market are Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca plc, Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Boehringer Ingelheim International GmbH, Boston Scientific Corporation, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Amneal Pharmaceuticals LLC, Mallinckrodt plc, Nevro Corp.

What Are the Key Drivers of the Chronic Pain Treatment Market?

Anticipated to fuel the expansion of the chronic pain treatment market, is the growing frequency of arthritis pain. Arthritis pain refers to joint discomfort, ache, or soreness due to inflammation or degeneration from arthritis. The increasing occurrence of this kind of pain is mainly due to an aging population, as natural joint degeneration and wear that comes with age lead to a higher incidence of arthritis-related conditions. By targeting nerve sensitivity and inflammation, chronic pain treatment aids in reducing discomfort caused by arthritis, improving joint function, and enhancing the overall living standard for individuals contending with persistent arthritis symptoms. For instance, per the UK’s Office for Health Improvement and Disparities, in 2023, in 2022, a long-term musculoskeletal (MSK) condition such as arthritis or persistent issues with their back or joints was reported by 17.6% of individuals 16 years and older. This shows an increase from the 17.0% reported in 2021. Hence, the growing incidence of arthritis pain contributes to the expansion of the chronic pain treatment market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24504&type=smp

What Are the Key Market Segments in the Chronic Pain Treatment Industry?

The chronic pain treatment market covered in this report is segmented –

1) By Product Type: Drugs, Devices

2) By Indication: Neuropathic Pain, Arthritis Pain, Chronic Back Pain, Cancer Pain, Migraine, Fibromyalgia, Other Indications

3) By Distribution channels: Direct, Indirect

4) By End-User: Hospitals, Clinics, Nursing Homes, Research Centers And Universities, Other End-Users

Subsegments:

1) By Drugs: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Opioids, Antidepressants, Anticonvulsants, Muscle Relaxants, Topical Analgesics, Other Pain Relief Medications

2) By Devices: Neuromodulation Devices, Transcutaneous Electrical Nerve Stimulation (TENS) Devices, Spinal Cord Stimulators, Peripheral Nerve Stimulators, Radiofrequency Ablation Devices, Implantable Drug Delivery Devices

What Are the Latest Trends in the Chronic Pain Treatment Market?

Focusing on the development of innovative products like rechargeable spinal cord stimulators is the main strategy of leading companies in the chronic pain treatment market to help improve patient convenience and optimise long-term pain management results. This medical device, that can be implanted near the spine, generates electrical pulses to nullify pain signals and can be externally recharged without the need for surgery. It is used to control chronic pain by inhibiting pain pathways in the spinal cord, lessening the pain experienced by people with conditions like failed back surgery syndrome or neuropathic pain. For instance, in December 2022, the Eterna spinal cord stimulation system was introduced by Abbott Laboratories, a medical device company based in the US. With a size smaller than an Apple AirPods case, Eterna is highly compact, discreet, and patient-friendly for managing chronic pain. Besides providing significant pain relief, it has shown potential in lowering dependency on opioid drugs and is designed for long-term and minimally invasive use, thereby improving patients’ overall daily functioning and quality of life.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/chronic-pain-treatment-global-market-report

What Are the Key Regional Markets in the Chronic Pain Treatment Industry?

North America was the largest region in the chronic pain treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic pain treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24504

This Report Delivers Insight On:

1. How big is the chronic pain treatment market, and how is it changing globally?

2. Who are the major companies in the chronic pain treatment market, and how are they performing?

3. What are the key opportunities and risks in the chronic pain treatment market right now?

4. Which products or customer segments are growing the most in the chronic pain treatment market?

5. What factors are helping or slowing down the growth of the chronic pain treatment market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model